A future for CD3 antibodies in immunotherapy of type 1 diabetes
- PMID: 30612137
- DOI: 10.1007/s00125-018-4808-7
A future for CD3 antibodies in immunotherapy of type 1 diabetes
Keywords: Autoimmune diabetes; CD3 monoclonal antibodies; Immunotherapy; T lymphocytes; Teplizumab; Type 1 diabetes.
Comment on
-
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.Diabetologia. 2019 Apr;62(4):655-664. doi: 10.1007/s00125-018-4786-9. Epub 2018 Dec 19. Diabetologia. 2019. PMID: 30569273 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
